Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 30 clinical trials
Featured trial
LixiLan-G EFC13794

LixiLan-G EFC13794

  • 644 views
  • 08 Nov, 2020
  • 1 location
Featured trial
You may be eligible to join the EMERGE STUDY if you

You may be eligible to join the EMERGE STUDY if you

  • 70 views
  • 25 Mar, 2021
  • 1 location
Pioglitazone as an Adjunct to Cognitive-Behavioral Therapy for Cocaine Relapse Prevention

The purpose of this study is to see how well pioglitazone, when used with cognitive behavioral therapy, works at helping people who have recently stopped using cocaine to continue to not use

  • 0 views
  • 16 Jun, 2022
  • 1 location
Pathophysiology of Uric Acid Nephrolithiasis (IUAN)

urine test results. Aim 2: The investigators will evaluate the effect of thiazolidinedione (pioglitazone) on excess fatty acid accumulation in kidney tissue and its correlation with uric acid

  • 8 views
  • 24 Jan, 2022
  • 1 location
Managing DIabetes Remission After Combined Therapy in EarLy Stage of DiabetEs

of a 4-month polychemotherapy (metformin+pioglitazone+sitagliptin+empagliflozin) regimen vs standard care in patients with newly diagnosed T2DM by an open label, pragmatic RCT. Mechanisms of action

  • 2 views
  • 23 Aug, 2021
  • 1 location
Therapies in Combination or Sequentially With Tyrosine Kinase Inhibitors (TKIs) in Chronic Phase Chronic Myelogenous Leukemia Patients in CCR (ACTIW) (ACTIW)

Patients will be randomized in phase II trials to continue on the same TKI versus one of the alternative treatment approaches. If a patient is not eligible for one of the treatments, he (she) will be randomized between the options for which he (she) is eligible. The trial will start …

  • 11 views
  • 23 Feb, 2022
  • 16 locations
Pioglitazone and SGLT2 Inhibitors vs. DPP4 Inhibitors in Patients With Stroke

combination of pioglitazone and a sodium glucose cotransporter 2 (SGLT-2) inhibitor, compared with a dipeptidyl peptidase-4 (DPP-4) inhibitor, reduces recurrent stroke in diabetic patients with recent

insulin resistance
metformin
cardiovascular disease
diabetes mellitus
glomerular filtration rate
  • 0 views
  • 24 Mar, 2022
  • 1 location
Preservation of Beta Cell Function in Pre-diabetes in Subject With Impaired Fasting Glucose (IFG) and Impaired Glucose Tolerance (IGT)

HYPOTHESIS: Impaired glucose tolerance (IGT) and impaired fasting glucose (IFG) have distinct pathophysiologic etiologies. Therefore, therapeutic interventions designed to correct the specific underlying pathogenic abnormalities in IGT and IFG will be required to optimally prevent the progressive beta cell failure and development of overt type 2 diabetes.

metformin
dapagliflozin
saxagliptin
impaired glucose tolerance
Accepts healthy volunteers
  • 39 views
  • 17 Sep, 2022
  • 1 location
Dapagliflozin Plus Pioglitazone in T1DM

Purpose: To examine the effect of addition of combination therapy with dapagliflozin plus pioglitazone to insulin on glucose control and plasma ketone concentration in patients with type 1

c-peptide
continuous glucose monitoring
ketoacidosis
tolerance test
dapagliflozin
  • 79 views
  • 22 Mar, 2022
  • 2 locations
Pioglitazone and Insulin Resistance in ADT

deprivation therapy (ADT) for prostate carcinoma as well as to investigate the role of pioglitazone therapy in reduction/ reversal of that insulin resistance

  • 0 views
  • 06 Nov, 2021
  • 1 location